Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Microsoft Corporation stock logo
MSFT
Microsoft
$503.21
-2.9%
$519.36
$349.20
▼
$559.15
$3.73T1.0533.23 million shs12.46 million shs
NVIDIA Corporation stock logo
NVDA
NVIDIA
$154.09
-1.3%
$213.16
$148.80
▼
$243.37
$3.70T2.21157.59 million shs210.00 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$76.31
-0.8%
$72.84
$50.82
▼
$85.84
$6.01B1.42787,147 shs85,382 shs
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$2.58
-11.2%
$3.76
$2.50
▼
$5.24
$1.60B1.1519.63 million shs25.02 million shs
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$25.81
-5.7%
$27.07
$10.94
▼
$34.00
$1.90B1.691.55 million shs631,012 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Microsoft Corporation stock logo
MSFT
Microsoft
-1.12%-4.99%-2.09%+7.55%+1.53%
NVIDIA Corporation stock logo
NVDA
NVIDIA
-4.12%-12.61%-27.08%-28.94%-17.89%
RadNet, Inc. stock logo
RDNT
RadNet
+0.62%-1.90%+11.76%+4.14%+2.32%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-8.81%-23.88%-16.18%-6.15%-29.95%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-7.35%-18.06%+21.06%+54.84%+55.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Microsoft Corporation stock logo
MSFT
Microsoft
$503.21
-2.9%
$519.36
$349.20
▼
$559.15
$3.73T1.0533.23 million shs12.46 million shs
NVIDIA Corporation stock logo
NVDA
NVIDIA
$154.09
-1.3%
$213.16
$148.80
▼
$243.37
$3.70T2.21157.59 million shs210.00 million shs
RadNet, Inc. stock logo
RDNT
RadNet
$76.31
-0.8%
$72.84
$50.82
▼
$85.84
$6.01B1.42787,147 shs85,382 shs
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$2.58
-11.2%
$3.76
$2.50
▼
$5.24
$1.60B1.1519.63 million shs25.02 million shs
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$25.81
-5.7%
$27.07
$10.94
▼
$34.00
$1.90B1.691.55 million shs631,012 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Microsoft Corporation stock logo
MSFT
Microsoft
-1.12%-4.99%-2.09%+7.55%+1.53%
NVIDIA Corporation stock logo
NVDA
NVIDIA
-4.12%-12.61%-27.08%-28.94%-17.89%
RadNet, Inc. stock logo
RDNT
RadNet
+0.62%-1.90%+11.76%+4.14%+2.32%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-8.81%-23.88%-16.18%-6.15%-29.95%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-7.35%-18.06%+21.06%+54.84%+55.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Microsoft Corporation stock logo
MSFT
Microsoft
2.94
Moderate Buy$609.5421.15% Upside
NVIDIA Corporation stock logo
NVDA
NVIDIA
2.81
Moderate Buy$272.7576.33% Upside
RadNet, Inc. stock logo
RDNT
RadNet
2.78
Moderate Buy$89.6717.10% Upside
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2.20
Hold$7.58185.50% Upside
Schrodinger, Inc. stock logo
SDGR
Schrodinger
2.38
Hold$26.672.29% Upside

Current Analyst Ratings Breakdown

Latest MSFT, NVDA, RXRX, RDNT, and SDGR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Set Price TargetBuy$300.00 ➝ $240.00
11/16/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Set Price TargetHigh Conviction Outperform ➝ Outperform$425.00 ➝ $255.00
11/16/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Initiated CoverageModerate Buy
11/16/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Lower Price TargetOutperform$250.00 ➝ $220.00
11/16/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Lower Price TargetBuy$275.00 ➝ $200.00
11/16/2026
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
Lower Price TargetOverweight$10.00 ➝ $7.00
11/13/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
DowngradeStrong-Buy ➝ Hold
11/13/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
DowngradeBuy ➝ Hold$188.00
11/13/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Lower Price TargetBuy$390.00 ➝ $300.00
11/13/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
DowngradeBuy ➝ Hold$170.00
11/13/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Lower Price TargetOverweight$275.00 ➝ $210.00
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Microsoft Corporation stock logo
MSFT
Microsoft
$331.84B11.26$21.68 per share23.21$63.36 per share7.94
NVIDIA Corporation stock logo
NVDA
NVIDIA
$215.94B17.26$4.40 per share35.18$6.47 per share23.91
RadNet, Inc. stock logo
RDNT
RadNet
$2.04B2.96$3.25 per share23.59$18.24 per share4.20
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$74.68M22.14N/AN/A$1.45 per share1.83
Schrodinger, Inc. stock logo
SDGR
Schrodinger
$255.87M7.52N/AN/A$4.09 per share6.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Microsoft Corporation stock logo
MSFT
Microsoft
$133.75B$19.1626.2321.131.5441.17%31.28%18.55%1/27/2027 (Estimated)
NVIDIA Corporation stock logo
NVDA
NVIDIA
$120.07B$7.9119.569.831.2863.66%96.04%71.00%11/17/2026 (Estimated)
RadNet, Inc. stock logo
RDNT
RadNet
-$18.65M-$0.29N/A75.81N/A-0.94%3.14%1.08%N/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$644.76M-$0.90N/AN/AN/A-697.15%-47.85%-36.26%N/A
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$103.26M-$0.79N/AN/AN/A-22.02%-18.12%-9.07%N/A

Latest MSFT, NVDA, RXRX, RDNT, and SDGR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/17/2026Q3 2027
NVIDIA Corporation stock logo
NVDA
NVIDIA
$2.48N/AN/AN/A$108.96 billionN/A
11/8/2026Q3 2026
RadNet, Inc. stock logo
RDNT
RadNet
$0.2214$0.30+$0.0786$0.05$639.97 million$638.26 million
11/4/2026Q3 2026
Schrodinger, Inc. stock logo
SDGR
Schrodinger
-$0.6665-$0.50+$0.1665-$0.50$47.73 million$64.49 million
11/2/2026Q3 2026 & Study Update
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$0.2190-$0.22-$0.0010-$0.22$14.81 million$18.55 million
10/28/2026Q1 2027
Microsoft Corporation stock logo
MSFT
Microsoft
$4.72$4.89+$0.17$4.92$90.62 billion$92.28 billion
8/26/2026Q2 2027
NVIDIA Corporation stock logo
NVDA
NVIDIA
$2.09$2.22+$0.13$2.46$92.27 billion$96.22 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Microsoft Corporation stock logo
MSFT
Microsoft
$3.640.70%+10.21%19.00%23 Years
NVIDIA Corporation stock logo
NVDA
NVIDIA
$1.000.64%+14.87%12.64%1 Years
RadNet, Inc. stock logo
RDNT
RadNet
N/AN/AN/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/AN/AN/AN/AN/A
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/AN/AN/AN/AN/A

Latest MSFT, NVDA, RXRX, RDNT, and SDGR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/14/2026
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.980.79%11/19/202611/19/202612/10/2026
8/26/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
quarterly$0.250.46%9/10/20269/10/202610/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Microsoft Corporation stock logo
MSFT
Microsoft
0.07
1.22
1.21
NVIDIA Corporation stock logo
NVDA
NVIDIA
0.14
4.59
3.85
RadNet, Inc. stock logo
RDNT
RadNet
0.90
1.49
1.48
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/A
5.01
5.01
Schrodinger, Inc. stock logo
SDGR
Schrodinger
N/A
2.75
2.75

Institutional Ownership

CompanyInstitutional Ownership
Microsoft Corporation stock logo
MSFT
Microsoft
71.13%
NVIDIA Corporation stock logo
NVDA
NVIDIA
65.27%
RadNet, Inc. stock logo
RDNT
RadNet
77.90%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
89.06%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
79.05%

Insider Ownership

CompanyInsider Ownership
Microsoft Corporation stock logo
MSFT
Microsoft
0.03%
NVIDIA Corporation stock logo
NVDA
NVIDIA
3.94%
RadNet, Inc. stock logo
RDNT
RadNet
5.14%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
6.65%
Schrodinger, Inc. stock logo
SDGR
Schrodinger
10.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
223,0007.43 billion7.42 billionOptionable
NVIDIA Corporation stock logo
NVDA
NVIDIA
42,00024.10 billion23.15 billionOptionable
RadNet, Inc. stock logo
RDNT
RadNet
11,26478.78 million74.73 millionOptionable
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
600622.76 million581.35 millionOptionable
Schrodinger, Inc. stock logo
SDGR
Schrodinger
85073.82 million67.50 millionOptionable

Recent News About These Companies

Schrödinger Earnings Call Highlights Growth and New Risks
Schrödinger (SDGR) Stock Could Be Undervalued On Its 67% Run
Schrodinger (NASDAQ:SDGR) EVP Sells $1,051,200.00 in Stock
UBS Sticks to Its Hold Rating for Schrodinger (SDGR)
Schrodinger (NASDAQ:SDGR) Price Target Raised to $36.00
Schrödinger (SDGR) Q3 2026 Earnings Call Transcript
What Schrodinger (SDGR) Said on Its Q3 Earnings Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Microsoft stock logo

Microsoft NASDAQ:MSFT

$503.21 -14.78 (-2.85%)
As of 01:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$154.08 -2.06 (-1.32%)
As of 01:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

RadNet stock logo

RadNet NASDAQ:RDNT

$76.31 -0.58 (-0.75%)
As of 01:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Recursion Pharmaceuticals stock logo

Recursion Pharmaceuticals NASDAQ:RXRX

$2.58 -0.33 (-11.21%)
As of 01:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Schrodinger stock logo

Schrodinger NASDAQ:SDGR

$25.81 -1.55 (-5.67%)
As of 01:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.